The Story of Amiodarone.

Eur Heart J

Cardiac Primary Prevention Research Center (CPPRC), Tehran Heart Center, Tehran University of Medical Sciences, West Jamali Alley, Vafamanesh St, Heravi Sq., Tehran, Iran.

Published: September 2019

Download full-text PDF

Source
http://dx.doi.org/10.1093/eurheartj/ehz583DOI Listing

Publication Analysis

Top Keywords

story amiodarone
4
story
1

Similar Publications

Can the Past Re-Shape the Future?: New Insights Into PVC-Mediated Cardiomyopathy From the CHF-STAT Trial and the Retelling of a Familiar Story.

JACC Clin Electrophysiol

March 2021

Department of Cardiology, Alfred Hospital, Melbourne, Australia; Department of Cardiology, Baker Heart and Diabetes Institute, Melbourne, Australia; Department of Cardiology, University of Melbourne, Melbourne, Australia; Department of Cardiology, Monash University, Melbourne, Australia.

View Article and Find Full Text PDF

No shocking updates for the lidocaine vs amiodarone in pediatric pVT/VF story.

Resuscitation

April 2020

University of Alberta, Pediatric Critical Care Medicine, Rm 4-539 (ECHA), 11405 87 Ave, Edmonton, AB T6G1C9, Canada; Stollery Children's Hospital, Pediatrics, Rm 4-539 (ECHA), 11405 87 Ave, Edmonton, AB T6G1C9, Canada. Electronic address:

View Article and Find Full Text PDF

The Story of Amiodarone.

Eur Heart J

September 2019

Cardiac Primary Prevention Research Center (CPPRC), Tehran Heart Center, Tehran University of Medical Sciences, West Jamali Alley, Vafamanesh St, Heravi Sq., Tehran, Iran.

View Article and Find Full Text PDF

Editorial: advances in the therapy of atrial fibrillation: incrementally progressive but not without missteps.

Curr Cardiol Rev

November 2014

ECG Laboratory, 6th floor, Milstein Pavilion, The New York Presbyterian Hospital, 177 Fort Washington Ave., New York, NY 10032, USA.

Advances in the therapy of atrial fibrillation (AF) have not come easily or quickly, despite the recognized need for significantly better antiarrhythmic agents for AF termination and prevention as well as for more user-friendly anticoagulants for the prevention of emboli in patients with AF. Rather, the road has been only slowly progressive and bumpy. This manuscript will introduce the recent issues with dronedarone, the complex development story for vernakalant, and the appearance of the new oral anticoagulants.

View Article and Find Full Text PDF

Ranolazine: Déjà vu of the amiodarone story.

Heart Rhythm

August 2011

Tel-Aviv Sourasky Medical Center and Sackler-School of Medicine, Tel Aviv University, Tel Aviv, Israel.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!